These three ANA subtypes (ATA, ACA, and anti-RNAP) permit to classify the majority of SSc patients and have been included in the last 2013 American College of Rheumatology/European League Against Rheumatism classification (28). This evidence concerns the gene BTG3 and systemic sclerosis.